2. Academic Validation
  3. Osmolarity-Directed Encapsulation of Size-Tuned Nanoparticles into Red Blood Cells

Osmolarity-Directed Encapsulation of Size-Tuned Nanoparticles into Red Blood Cells

  • Small Methods. 2025 Dec 12:e01437. doi: 10.1002/smtd.202501437.
Shihao Bai 1 2,  Shiying Hou 1 2,  Tianxiang Chen 1 2,  Xuehua Ma 1 2,  Jie Lin 1 2,  Changyong Gao 1 2,  Aiguo Wu 1 2
Affiliations

Affiliations

  • 1 Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials at Ningbo Cixi Institute of Biomedical Engineering, Institute of Biomedical Engineering at Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.
  • 2 University of Chinese Academy of Sciences, Beijing, 100049, China.
PMID: 41388650 DOI: 10.1002/smtd.202501437
Abstract

Red blood cells (RBCs) have emerged as promising carriers for therapeutic and diagnostic agents due to their long circulation time, biocompatibility, and immune-evasive properties. Hypotonic encapsulation is the most widely employed technique; however, the correlation between nanoparticle sizes and the hypotonic osmolarities required for efficient encapsulation remains unclear. In this study, the size-dependent osmolarity requirements governing nanoparticles into RBCs are investigated. Using monodisperse gold nanoparticles as model systems, the optimal osmolarity correlated with nanoparticle diameter is identified as 150 mOsm for particles ≤33 nm, 100 mOsm for particles 66-91 nm, and 50 mOsm for particles ≈133 nm. These conditions maximized encapsulation efficiency while maintaining RBC membrane integrity and preserving the expression of key surface proteins, including CD47. The applicability of this approach is further validated using nanoparticles of diverse compositions and zeta potentials. In vitro assays demonstrated minimal hemolysis and significantly reduced macrophage uptake across all formulations. Complementary in vivo imaging reveals prolonged systemic circulation and biodistribution profiles that closely resemble those of native RBCs. This study establishes a standardized, size-adaptive hypotonic encapsulation protocol, offering a versatile and scalable platform for engineering RBC-based carriers with broad translational potential in nanomedicine.

Keywords

hypotonic encapsulation; nanoparticle size; osmolarity; red blood cell carriers.

Figures
Products